Home › SEC Filings › Current Report (8-K)
Current Report (8-K)
All Current Report (8-K)Annual Report (10-K)Quarterly Report (10-Q)Form 4 Insider TradesSC 13D Beneficial Ownership13F Institutional HoldingsPress ReleasesInsider Cluster ActivityInsider Buy Activity
Theme?
All themes Artificial IntelligenceSemiconductorsQuantum ComputingSpace & SatellitesRobotics & AutomationElectric VehiclesClean & Renewable EnergyBattery & Energy StorageNuclear & FusionCybersecurityCloud & SaaSFintech & PaymentsCrypto & BlockchainGenomics & Gene EditingBiotech & Drug DiscoveryE-commerce & PlatformsStreaming & Digital MediaGaming & EsportsDefense TechCannabis
| Ticker | Type | Sentiment | Impact | Summary | Date |
|---|---|---|---|---|---|
| MOH | 8-K | mixed | 6/10 | Molina Healthcare reported Q3 2026 adjusted EPS of $0.89, beating consensus of $0.63 by 41.3%, on premium revenue of $10 | Oct 21, 2026 |
| QS | 8-K | neutral | 5/10 | QuantumScape reported Q3 2026 GAAP net loss of $84.5M ($0.14 per share), narrower than the $105.8M loss ($0.18 per share | Oct 21, 2026 |
| ESI | 8-K | bullish | 7/10 | Element Solutions reported record Q3 2026 results with net sales of $995M (+52% YoY, +13% organic) and adjusted EPS of $ | Oct 21, 2026 |
| ARR | 8-K | bearish | 7/10 | Armour Residential REIT reported Q3 2026 Distributable Earnings of $0.71 per share, essentially in line with the $0.70 c | Oct 21, 2026 |
| WEST | 8-K | mixed | 6/10 | Westrock Coffee closed a $600M refinancing of its Beverage Solutions credit facilities, consisting of a $300M term loan | Oct 21, 2026 |
| CCI | 8-K | mixed | 5/10 | Crown Castle reported Q3 2026 AFFO of $1.24 per share, beating the $1.16 consensus by 6.9%, but site rental revenues dec | Oct 21, 2026 |
| IPDN | 8-K | bearish | 6/10 | Professional Diversity Network entered into three Securities Purchase Agreements to sell 146,713 shares at $1.704 per sh | Oct 21, 2026 |
| MDLN | 8-K | bearish | 6/10 | Medline initiated a voluntary field action to remove and discontinue all Medline Brand beds (homecare, bariatric, long-t | Oct 21, 2026 |
| FNLC | 8-K | bullish | 6/10 | First Bancorp reported record Q3 2026 net income of $10.7M ($0.95 diluted EPS), up 17.5% YoY from $9.1M ($0.81), driven | Oct 21, 2026 |
| NVEC | 8-K | bearish | 5/10 | NVE Corp reported Q2 fiscal 2027 results with total revenue declining 8% YoY to $5.83M and net income down 4% to $3.17M | Oct 21, 2026 |
| LUV | 8-K | mixed | 6/10 | Southwest Airlines reported Q3 2026 GAAP diluted EPS of $0.55, a 30.4% miss vs consensus of $0.79, though the Street-tra | Oct 21, 2026 |
| NAVI | 8-K | neutral | 5/10 | Navient Corporation announced a plan to implement a new holding company structure via a tax-free internal reorganization | Oct 21, 2026 |
| GITS | 8-K | neutral | 3/10 | Global Interactive Technologies appointed Amy Shi as Executive Chair of the Board, effective October 15, 2026. The compe | Oct 21, 2026 |
| BTCO | 8-K | neutral | 2/10 | The Principal Financial and Accounting Officer of the sponsor, Kelli Gallegos, began a leave of absence effective Octobe | Oct 21, 2026 |
| MEDP | 8-K | bullish | 6/10 | Medpace reported Q3 2026 revenue of $716.0M (+8.5% YoY) and GAAP diluted EPS of $4.84, slightly below consensus estimate | Oct 21, 2026 |
| RPT | 8-K | neutral | 4/10 | Rithm Property Trust reported Q3 2026 GAAP comprehensive income of $1.3 million ($0.17 per diluted share), in line with | Oct 21, 2026 |
| IONS | 8-K | bullish | 7/10 | Ionis Pharmaceuticals' partner GSK announced FDA approval of HIBSAGO (bepirovirsen) for chronic hepatitis B, a first-in- | Oct 21, 2026 |
| FAF | 8-K | mixed | 5/10 | First American Financial reported Q3 2026 adjusted EPS of $1.78, beating consensus of $1.69 by 5.3%, on revenue of $2.08 | Oct 21, 2026 |
| CCNE | 8-K | neutral | 5/10 | CNB Financial reported Q3 2026 EPS of $0.91, a 1.1% beat vs consensus of $0.90, on revenue of $87.8M (below the $89.1M e | Oct 21, 2026 |
| NTST | 8-K | bullish | 5/10 | NETSTREIT reported Q3 2026 AFFO of $0.35 per diluted share, beating the $0.33 consensus by 6.1%, while total revenue of | Oct 21, 2026 |
| LRCX | 8-K | bullish | 7/10 | Lam Research reported FQ1 2027 (Sep 2026) revenue of $8.22B and GAAP diluted EPS of $2.19, missing consensus estimates o | Oct 21, 2026 |
| TFIN | 8-K | bearish | 6/10 | Triumph Financial reported Q3 2026 net income of $12.6M ($0.52 diluted EPS), missing the consensus estimate of $0.60 by | Oct 21, 2026 |
| UUP | 8-K | neutral | 2/10 | The Invesco DB US Dollar Index Trust and its underlying series (UUP and UDN) disclosed that Kelli Gallegos, Principal Fi | Oct 21, 2026 |
| WDFC | 8-K | bearish | 6/10 | WD-40 Company reported Q4 FY2026 results that missed consensus estimates, with EPS of $1.06 (vs $1.32 consensus, -19.7% | Oct 21, 2026 |
| TCBI | 8-K | bullish | 6/10 | Texas Capital Bancshares reported Q3 2026 GAAP diluted EPS of $2.28, a 13.4% beat vs the $2.01 consensus, on total reven | Oct 21, 2026 |
| KMI | 8-K | mixed | 6/10 | Kinder Morgan reported record Q3 2026 results with EPS of $0.34 (GAAP) and Adjusted EPS of $0.35, both up 21% YoY, but G | Oct 21, 2026 |
| DBC | 8-K | neutral | 2/10 | Invesco DB Commodity Index Tracking Fund disclosed that Kelli Gallegos, Principal Financial and Accounting Officer of th | Oct 21, 2026 |
| RCUS | 8-K | neutral | 4/10 | Arcus Biosciences disclosed a preliminary Q3 2026 cash balance of ~$694M, down from $876M at Q2 end and $1.01B at year-e | Oct 21, 2026 |
| EGP | 8-K | bullish | 6/10 | EastGroup Properties reported Q3 2026 FFO of $2.45 per share, beating the $2.43 consensus estimate by 0.8%, and raised f | Oct 21, 2026 |
| DFDV | 8-K | neutral | 3/10 | Two board members, Adam Townsend and Thomas Perfumo, resigned from the DeFi Development Corp. board effective immediatel | Oct 21, 2026 |